T. Rowe Price Associates
RXO icon

T. Rowe Price Associates’s RXO RXO Stock Holding History

T. Rowe Price Associates’s Portfolio RXO Stock Details RXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.38M Buy
231,159
+37,573
+19% +$830K ﹤0.01% 1456
2026
Q1 		$2.83M Buy
193,586
+30,491
+19% +$447K ﹤0.01% 1677
2025
Q4 		$2.06M Buy
163,095
+20,893
+15% +$308K ﹤0.01% 1737
2025
Q3 		$2.19M Buy
142,202
+9,575
+7% +$154K ﹤0.01% 1700
2025
Q2 		$2.08M Buy
132,627
+15,791
+14% +$239K ﹤0.01% 1617
2025
Q1 		$2.23M Buy
116,836
+11,070
+10% +$242K ﹤0.01% 1555
2024
Q4 		$2.52M Buy
105,766
+17,424
+20% +$486K ﹤0.01% 1545
2024
Q3 		$2.47M Buy
88,342
+7,189
+9% +$203K ﹤0.01% 1542
2024
Q2 		$2.12M Buy
81,153
+5,351
+7% +$111K ﹤0.01% 1527
2024
Q1 		$1.66M Buy
75,802
+1,663
+2% +$35.6K ﹤0.01% 1667
2023
Q4 		$1.73M Sell
74,139
-562,930
-88% -$11.3M ﹤0.01% 1613
2023
Q3 		$12.6M Sell
637,069
-31,058
-5% -$612K ﹤0.01% 1023
2023
Q2 		$15.1M Buy
668,127
+156,871
+31% +$3.16M ﹤0.01% 1008
2023
Q1 		$10M Buy
511,256
+1,115
+0.2% +$21.4K ﹤0.01% 1052
2022
Q4 		$8.78M Buy
+510,141
New +$9.05M ﹤0.01% 1076

Other funds holding RXO

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

T. Rowe Price Associates's RXO Position: Q2 2026 in Review

T. Rowe Price Associates increased its RXO (RXO) stake by 19% in Q2 2026, buying an estimated $830K and bringing the position to 231,159 shares worth $6.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1456.

T. Rowe Price Associates first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $15.1M in Q2 2023. 304 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • T. Rowe Price Associates held 231,159 shares of RXO worth $6.38M as of Q2 2026.
  • T. Rowe Price Associates bought 37,573 RXO shares in Q2 2026, an estimated $830K.
  • RXO made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1456 holding.
  • T. Rowe Price Associates first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • T. Rowe Price Associates's RXO position peaked at $15.1M in Q2 2023.
  • 304 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.